1. Introduction {#S1}
===============

Changes in carbon dioxide levels are known to alter cerebral blood flow \[[@R1]\]. Hypercapnia studies have been carried out in healthy volunteers to characterise brain tissue oxygenation and blood flow changes, measured with near-infrared spectroscopy (NIRS) and transcranial Doppler (TCD) \[[@R2]\].

Here we apply the BrainSignals model \[[@R3]\], a physiological model of brain circulation and metabolism, to data from a hypercapnia study in healthy adults \[[@R4]\]. The model predicts several physiological variables, including those which can be measured with NIRS and TCD. It has previously been used successfully to de scribe the effects of hypoxia, also in healthy adults. We aimed to reproduce the experimental results as closely as possible with the model, and in doing so, enhance our understanding of the measurements, and the effects of hypercapnia.

2. The BrainSignals model {#S2}
=========================

The structure of the model is illustrated in [Figure 1](#F1){ref-type="fig"}. The circulatory part of the model comprises three compartments: arteries and aterioles, capillaries and veins. The venous and capillary volumes are fixed, but the arterial/arteriolar compartment has variable resistance which is sensitive to four input variables: the arterial pressure of carbon dioxide (PaCO~2~), the arterial oxygen saturation, the mean arterial blood pressure (MBP), and a parameter representing neuronal activation. PaCO~2~ affects the resistance via the following equations. $$\frac{d\nu}{dt} = \frac{1}{\tau}(\text{PaCO}_{2} - \nu)$$ $$\eta = R_{C}\left( \frac{\nu}{\nu_{n}} - 1 \right) + \ldots$$

![A diagram of the BrainSignals model\
Inputs are shown in solid ovals and outputs in dashed ovals. Model processes are shown in rectangles. Figure reproduced from Banaji *et al.* \[[@R3]\].](AdvExpMedBiol-737-293-g001){#F1}

Here, *τ* is a time constant, and *ν* represents a low-pass filtered version of PaCO~2~ with normal value ν~n~. *R~C~* is a parameter controlling the magnitude of the response to PaCO~2~ changes and has a default value of 2.2. The muscular tension in the arterial wall depends on *η*, which is the sum of the PaCO~2~ term shown and three similar terms for the other input variables listed above. An average vessel radius is calculated from the balance of pressures and tensions in the vessel wall. This in turn determines the resistance of the arterial/arteriolar tree via Poiseuille's law. An increase in vessel radius leads to an increase in blood volume and blood flow. The model output of velocity of blood in the middle cerebral artery (Vmca) is proportional to cerebral blood flow.

All blood compartments have a fixed haemoglobin concentration \[Hb\] whose default value in the model is 2.275mM. In each compartment, a fraction of this haemoglobin is oxygenated. These fractions are determined from the arterial oxygen saturation (a model input), and from the rate of oxygen transport to the mitochondria for respiration. The tissue oxygen saturation (TOS) is the overall percentage of oxygenated haemoglobin in the arteries and veins. The steady state changes of Vmca and TOS with default model parameters and varying PaCO~2~ are shown in [Figure 2](#F2){ref-type="fig"}.

![Prediction o f Vmca and TOS by the model at different PaCO~2~ values](AdvExpMedBiol-737-293-g002){#F2}

3. Methods {#S3}
==========

Data were analysed from a hypercapnia study of fourteen healthy adult volunteers \[[@R4]\]. This involved a 1.5 kPa increase in end tidal CO~2~ (EtCO~2~) for 10 min, with 5 min at baseline before and after. Throughout the study, the subjects\' heart rate, mean blood pressure (MBP) and arterial oxygen saturation (SaO~2~) were monitored. The blood velocity in the middle cerebral artery (Vmca) was also monitored, using transcranial Doppler. The tissue oxygen saturation (TOS), a measure of the percentage of oxygenated haemoglobin, was obtained using the NIRO 300 (Hamamatsu Photonics KK). All signals were smoothed and filtered, and any periods with obvious instrumentation noise were identified by inspection and replaced by a linear interpolation. SaO~2~, EtCO~2~ and MBP were input to the model, and its outputs compared with the measured Vmca and TOS.

Parameter optimisation was carried out using a version of Powell\'s method implemented in SciPy \[[@R5]\]. The rms difference between a measured and simulated signal was calculated by a numerical integration of the squared difference between the two signals, over all time points. The aim of optimisation was to minimise this rms difference for each subject, using TOS, Vmca, or a weighted combination of the two. For Vmca, the simulated data from each parameter set was rescaled so that its average value matched that of the measured data, prior to error calculation. Initially, two model parameters were optimised: blood haemoglobin concentration \[Hb\] (or haematocrit), chosen for its influence on the absolute TOS value, and *R~C~*, which represents the sensitivity of the flow response to PaCO~2~ changes.

The success of a simulated dataset was judged by its rms difference, and also by comparing its response with that of the measured data. To calculate the response, a period of hypercapnia and a subsequent baseline period were identified by inspection of the EtCO~2~ trace for each subject. The response was then calculated from the means during these periods, after resampling to 1 Hz, as follows $$\text{Vmca\ response} = \frac{\text{Vmca(hypercapnia)\ -Vmca(baseline)}}{\text{Vmca(baseline)}} \times 100\%$$

After analysing the results, three new mechanisms were added to the model in turn. Firstly, to simulate an extracerebral contribution to TOS, TOS(corrected) was calculated as the weighted sum of intra and extracerebral compartments where *t* is the fractional contribution of the extracerebral compartment, and TOS(e) its fixed TOS value. TOS(i), the intracerebral TOS, was calculated as before. TOS(e) and *t* were optimised together with *R~C~*. Secondly, venous volume was varied with CO~2~ levels. Previously, it was fixed at 0.75 of the normal total blood volume (V~blood,n~). This was changed to where PaCO~2,n~ is the model's normal value of PaCO~2~. The constant *v* was included as an optimisation parameter. Finally, a change linking metabolic rate to CO~2~ levels was introduced, via a parameter representing the demand. This was varied in a similar way to venous volume and *d* was optimised. Changes in demand also have a direct effect on the blood flow; but this was removed here by setting the relevant parameter *R~u~* to zero.

4. Results {#S4}
==========

The measured data are summarised in [Table 1](#T1){ref-type="table"}. The mean (± SD) TOS and Vmca responses were 1.1 ± 0.8% and 26 ± 11%, respectively.

###### Summary of the measured data, mean (SD) across the 14 subjects

                   Normocapnia   Hypercapnia
  ---------------- ------------- -------------
  Duration (s)     240 (20)      500 (50)
  EtCO~2~ (kPa)    5.2 (0.3)     6.9 (0.3)
  TOS (%)          69 (6)        70 (6)
  Vmca (cms^−1^)   42 (11)       52 (13)

The six differently optimised datasets are summarised in [Table 2](#T2){ref-type="table"}. Parameter values not given in the table were set at their defaults, except for \[Hb\]. In optimisations 2 and 4--6 \[Hb\] was fixed at its value from optimisation 1. The errors in TOS and Vmca response for each subject in each of these optimisation sets, and for no optimisation, are shown in [Figure 3](#F3){ref-type="fig"}. With no optimisation, mean simulated TOS response was 7.1 ± 1.1%. Vmca was better predicted, with a mean response of 32 ± 6%. The response of each signal could be matched well when optimising to that signal alone. The parameter \[Hb\] was not included in the Vmca optimisation since it only had a small effect on the response. The mean value of *R~C~* resulting from optimisation 2 was significantly larger than that from optimisation 1; i.e. a greater sensitivity of blood flow to CO~2~ was required to explain the changes measured in Vmca, than that required to explain the changes measured in TOS. Consequently, optimisation 3, which attempted to match both signals, was less successful: in every subject, simulated TOS response was too large, whilst simulated Vmca response was too small.

###### Details of the optimisation methods and results

The first row contains the mean (SD) across the 14 subjects of the optimised parameter values. No value given indicates that a parameter was fixed.

  Optimisation                       1           2           3            4             5             6
  ---------------------- ----------- ----------- ----------- ------------ ------------- ------------- -----------
  Parameters optimised   *R~C~*      0.3 (0.2)   1.5 (0.6)   1.1 (0.4)    1.6 (0.6)     1.4 (0.6)     1.2 (0.4)
  \[Hb\] (mM)            2.1 (0.7)   \-          2.0 (0.7)   \-           \-            \-            
  *t*                    \-          \-          \-          0.79 (.13)   \-            \-            
  TOS(e) (%)             \-          \-          \-          69 (6)       \-            \-            
  *v* (mmHg)^−1^         \-          \-          \-          \-           0.06 (0.05)   \-            
  *d* (mmHg)^−1^         \-          \-          \-          \-           \-            0.16 (0.05)   
                                                                                                      
  Signals                TOS         x           \-          x            x             x             x
  optimised to           Vmca        \-          x           x            x             x             x

![Modelled response minus measured response for TOS vs Vmca\
The response is the difference (TOS) or percentage change (Vmca) of the mean at hypercapnia from the mean at baseline. The legend refers to the six optimisation methods described in [Table 2](#T2){ref-type="table"}. Series 0 represents no optimisation. Each point within a series represents a subject. The box at the origin surrounds all the points from optimisations 4--6, where new mechanisms were introduced.](AdvExpMedBiol-737-293-g003){#F3}

All three new model mechanisms reduced this discrepancy. The additional compartment for TOS was the most successful, leading to simulated TOS and Vmca responses of 1.1 ± 0.6% and 22 ± 6%. The mean optimum weight of the extracerebral compartment was 0.8 (range 0.45--0.95). With a varying venous volume, simulated response was reduced to 1.6 ± 0.9% for TOS and 20 ± 7%, for Vmca, and therefore matched better the measured signals. However, this corresponded to a mean venous volume change of 100%, (range 20--230%). When optimising the change in oxygen metabolism, the mean resulting cerebral metabolic rate of oxygen consumption (CMRO~2~) increase was 18 ± 8.5%. Simulated TOS and Vmca responses were 1.5 ± 0.9% and 21 ± 8% which matched well with the measured signals. An example of the CMRO~2~ change in one subject, along with the measured and modelled TOS and Vmca, is shown in [Figure 4](#F4){ref-type="fig"}.

![Examples of TOS, Vmca and CMRO~2~ from one volunteer\
The graphs show the measured signal (solid black), the modelled signal after optimisation 3 (dashed) and the modelled signal after optimisation 6 (solid grey).](AdvExpMedBiol-737-293-g004){#F4}

5. Discussion {#S5}
=============

As expected, Vmca and TOS increased during hypercapnia. The model behaviour was qualitatively correct, but consistently overestimated the ratio of TOS response to Vmca response. All three additional mechanisms reduced this discrepancy; however, the magnitude of the changes required for optimum fitting suggested that no single mechanism is likely to be successful in its own right.

TOS has been shown to have a high sensitivity and specificity to intracerebral changes \[[@R6]\]. It is surprising therefore, that an 80:20 extracerebral to intracerebral weighting was required to optimise the fitting of the TOS data.

The method of changing venous volume was very simplistic. A more realistic method could be incorporated, as in other models \[[@R7]\]. However, a large change in venous volume would still be required to fit TOS response accurately. Evidence from PET studies indicates that the cerebral blood volume changes seen during hypercapnia are caused primarily by arterial volume changes \[[@R8]\]. Our optimization suggests a doubling of the venous volume during the hypercapnia challenge, which seems unlikely.

Finally, linking of CMRO~2~ to CO~2~ levels allowed improved simulations of Vmca and TOS. But as before, the 18% increase was unexpectedly large. Changes in brain blood flow and oxygenation during CO~2~ challenges are well documented; however, there are still open questions regarding the changes in metabolism \[[@R9]\]. CO~2~ is usually assumed to be metabolically neutral. For example, in fMRI studies, hypercapnia is often used with this assumption to estimate oxygen metabolism changes from the BOLD signal \[[@R10]\]. However, recently Tachtsidis and colleagues have analysed the NIRS measured change in concentration of cytochrome c oxidase (CCO), and reported an increase in the CCO redox state in healthy volunteers during hypercapnia, that cannot be exclusively attributed to the increase in oxygen delivery \[[@R4]\]. We are currently exploring whether CCO measurements can provide additional data to help discriminate between the different hypotheses presented above.

In conclusion, there is an anomalous (small) change of TOS in response to hypercapnia that cannot be explained by optimisation of a single parameter in our model. We are currently attempting to optimise to a combination of factors simultaneously. If this does not prove possible it will suggest that TOS as measured optically does not report on the cerebral oxygen saturation as defined in our model,
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